DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hepatitis B virus (HBV) infection. METHODS: The USPSTF reviewed the evidence on the benefits and harms of antiviral treatment, the benefits of education or behavior change counseling, and the association between improvements in intermediate and clinical outcomes after antiviral therapy. POPULATION: This recommendation applies to asymptomatic, nonpregnant adolescents and adults at high risk for HBV infection (including those at high risk who were vaccinated before being screened for HBV infection). RECOMMENDATION: The USPSTF concludes that persons at high risk for infection should be screened for HBV infection. (B recommendation).
DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hepatitis B virus (HBV) infection. METHODS: The USPSTF reviewed the evidence on the benefits and harms of antiviral treatment, the benefits of education or behavior change counseling, and the association between improvements in intermediate and clinical outcomes after antiviral therapy. POPULATION: This recommendation applies to asymptomatic, nonpregnant adolescents and adults at high risk for HBV infection (including those at high risk who were vaccinated before being screened for HBV infection). RECOMMENDATION: The USPSTF concludes that persons at high risk for infection should be screened for HBV infection. (B recommendation).
Authors: Timothy Wang; Yu Liu; Duke Letran; Julie Ha Thi Dang; Aaron M Harris; Chin-Shang Li; Moon S Chen; Christopher L Bowlus; Eric Chak Journal: J Community Health Date: 2020-04
Authors: Aaron M Harris; Ben T Schoenbachler; Gilberto Ramirez; Claudia Vellozzi; Geoff A Beckett Journal: Public Health Rep Date: 2016 May-Jun Impact factor: 2.792
Authors: Cynthia Jorgensen; Sherry Chen; C Amanda Carnes; Joan Block; Daniel Chen; Jeffrey Caballero; Kate Moraras; Chari Cohen Journal: Public Health Rep Date: 2016 May-Jun Impact factor: 2.792
Authors: Jessica P Hwang; Danmeng Huang; John M Vierling; Maria E Suarez-Almazor; Ya-Chen Tina Shih; Mariana Chavez-MacGregor; Zhigang Duan; Sharon H Giordano; Dawn L Hershman; Michael J Fisch; Scott B Cantor Journal: JCO Clin Cancer Inform Date: 2019-03
Authors: Carlos L Arteaga; Peter C Adamson; Jeffrey A Engelman; Margaret Foti; Richard B Gaynor; Susan G Hilsenbeck; Paul J Limburg; Scott W Lowe; Elaine R Mardis; Scott Ramsey; Timothy R Rebbeck; Andrea L Richardson; Eric H Rubin; George J Weiner Journal: Clin Cancer Res Date: 2014-09-16 Impact factor: 12.531
Authors: Meheret Endeshaw; Benjamin D Hallowell; Hilda Razzaghi; Virginia Senkomago; Matthew T McKenna; Mona Saraiya Journal: Cancer Date: 2018-11-27 Impact factor: 6.860
Authors: A Blythe Ryerson; Christie R Eheman; Sean F Altekruse; John W Ward; Ahmedin Jemal; Recinda L Sherman; S Jane Henley; Deborah Holtzman; Andrew Lake; Anne-Michelle Noone; Robert N Anderson; Jiemin Ma; Kathleen N Ly; Kathleen A Cronin; Lynne Penberthy; Betsy A Kohler Journal: Cancer Date: 2016-03-09 Impact factor: 6.860
Authors: Karen Colbert Maresso; Kenneth Y Tsai; Powel H Brown; Eva Szabo; Scott Lippman; Ernest T Hawk Journal: CA Cancer J Clin Date: 2015-08-18 Impact factor: 508.702